Come up with a name for your new list and we'll add to it:
Alector raised a round of funding on March 10, 2014. Investors include
Johnson & Johnson Innovation.
Alector is a neurology-focused startup that is pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. Th…